Xue N., Hong D., Zhang D., et al. Engineering IscB to develop highly efficient miniature editing tools in mammalian cells and embryos. Molecular Cell (2024).
Wang X., Wu X., Tan B., et al. Allogeneic CD19-targeted CAR-T therapy in severe myositis and systemic sclerosis achieved durable remission and reversed extensive fibrotic damages. Cell (2024).
Yang L., Huo Y., Wang M., et al. Engineering APOBEC3A deaminase for highly accurate and efficient base editing. Nature Chemical Biology (2024).
